Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Active Biotech AB

Market Cap 154M 16.43M 14.18M 13.03M 12.27M 23.05M 1.55B 23.25M 60.14M 761M 61.68M 60.36M 2.63B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 154M 16.43M 14.18M 13.03M 12.27M 23.05M 1.55B 23.25M 60.14M 761M 61.68M 60.36M 2.63B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
81.52%
Yield 2026 *
-
Yield 2027 * -
1 day-9.24%
1 week+6.10%
Current month-6.64%
1 month-1.21%
3 months+16.44%
6 months+39.03%
Current year+41.78%
1 month 0.08
Extreme 0.0813
7.95
Current year 0.08
Extreme 0.0813
8.61
1 year 0.08
Extreme 0.0813
21.3
3 years 0.08
Extreme 0.0813
32.9
5 years 0.08
Extreme 0.0813
153
10 years 0.08
Extreme 0.0813
1,992.17
Manager TitleAgeSince
Chief Executive Officer 64 2017-06-30
Director of Finance/CFO 75 1999-12-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 70 2011-04-06
Chairman 61 2019-05-22
Director/Board Member 76 2019-05-22
Change 5-day change 1-year change 3-year change Capi.($)
-23.88%+6.10% - - 16.47M
+3.23%+2.25%+65.02%+116.66% 54.54B
+0.04%+5.05%+43.44%+36.75% 43.86B
+3.93%+7.34%-11.90%-15.89% 22.63B
+3.03%+6.42%-2.50%+383.80% 20.7B
-0.53%-0.27%+12.68%-37.07% 15.84B
+5.27%+1.87%+13.67%-38.00% 14.83B
+1.46%+0.02%+27.17%+177.67% 13.1B
-5.17%+4.13%+13.12% - 12.66B
-0.16%+5.66%+78.11%+102.87% 11.56B
Average +0.15%+0.18%+26.53%+90.85% 23.3B
Weighted average by Cap. +1.64%+0.18%+33.18%+90.97%

Financials

2026 *2027 *
Net sales - -
Net income -33.2M -3.53M -3.05M -2.8M -2.64M -4.95M -333M -5M -12.93M -164M -13.26M -12.97M -566M 18.2M 1.94M 1.67M 1.54M 1.45M 2.72M 183M 2.74M 7.09M 89.68M 7.27M 7.11M 310M
Net Debt - -
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
5
Date Price Change Volume
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Net sales - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!